Milton J Wallace - Net Worth and Insider Trading
Milton J Wallace Net Worth
The estimated net worth of Milton J Wallace is at least $12 Million dollars as of 2024-11-13. Milton J Wallace is the Director of Catalyst Pharmaceuticals Inc and owns about 539,184 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $12 Million. Details can be seen in Milton J Wallace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Milton J Wallace has not made any transactions after 2012-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Milton J Wallace
Milton J Wallace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Milton J Wallace owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Milton J Wallace’s form 4 insider trades.
Insider Ownership Summary of Milton J Wallace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-29 | director |
Milton J Wallace Latest Holdings Summary
Milton J Wallace currently owns a total of 1 stock. Milton J Wallace owns 539,184 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 29, 2012, with a value of $12 Million.
Latest Holdings of Milton J Wallace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-29 | 539,184 | 23.04 | 12,422,799 |
Holding Weightings of Milton J Wallace
Milton J Wallace Form 4 Trading Tracker
According to the SEC Form 4 filings, Milton J Wallace has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 11,100 shares on May 29, 2012, which cost Milton J Wallace around $6,327.
Insider Trading History of Milton J Wallace
- 1
Milton J Wallace Trading Performance
GuruFocus tracks the stock performance after each of Milton J Wallace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Milton J Wallace is 75.31%. GuruFocus also compares Milton J Wallace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Milton J Wallace within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Milton J Wallace's insider trading performs compared to the benchmark.
Performance of Milton J Wallace
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.52 | | | | | |
| Relative Return to S&P 500(%) | -15.17 | | | | | |
Milton J Wallace Ownership Network
Ownership Network List of Milton J Wallace
Ownership Network Relation of Milton J Wallace
Milton J Wallace Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Milton J Wallace is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Milton J Wallace made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Milton J Wallace Mailing Address
Above is the net worth, insider trading, and ownership report for Milton J Wallace. You might contact Milton J Wallace via mailing address: 1200 Brickell Ave, Suite 1720, Miami Fl 33131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
